This inventor holds 1 USPTO granted patent. Top assignees: Seattle Children's Hospital, The University of Queensland. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021
Title: Muhammad J A Shiddiky: Innovator in Biofragment Compositions
Introduction
Muhammad J A Shiddiky is a notable inventor based in Saint Lucia, Australia. He has made significant contributions to the field of biofragment compositions, which have important applications in antigen detection.
Latest Patents
Shiddiky holds a patent for "Cell-free biofragment compositions and related systems, devices, and methods." This patent describes biofragment compositions that include bioparticle fragments and at least one heterologous antigen-binding molecule. The biofragment is typically derived from a larger, intact bioparticle that expresses the heterologous antigen-binding molecule at its surface. The biofragment has increased solubility, which facilitates assays for antigen detection. The patent also covers methods of using and making these biofragment compositions, as well as systems and devices that implement them. Notably, these methods do not require additional detection reagents, such as animal-derived detection antibodies.
Career Highlights
Throughout his career, Shiddiky has worked with prestigious institutions, including the University of Queensland and Seattle Children's Hospital. His work has focused on advancing the understanding and application of biofragment technologies.
Collaborations
Some of his notable coworkers include Yadveer Grewal and Gerard A Cangelosi. Their collaborative efforts have contributed to the development of innovative solutions in the field.
Conclusion
Muhammad J A Shiddiky is a pioneering inventor whose work in biofragment compositions has the potential to enhance antigen detection methods significantly. His contributions to the field are noteworthy and continue to influence research and development in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile